May 22, 2023, Caribou Biosciences Inc. (NASDAQ: CRBU) trading session started at the price of $4.34, that was 10.14% jump from the session before. During the day, the shares moved up to $4.825 and dropped to $4.31 before settling in for the closing price of $4.34. A 52-week range for CRBU has been $4.05 – $13.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -47.20%. With a float of $54.41 million, this company’s outstanding shares have now reached $61.19 million.
Let’s look at the performance matrix of the company that is accounted for 137 employees. In terms of profitability, gross margin is +73.71, operating margin of -768.17, and the pretax margin is -717.28.
Caribou Biosciences Inc. (CRBU) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Caribou Biosciences Inc. stocks. The insider ownership of Caribou Biosciences Inc. is 1.30%, while institutional ownership is 72.10%. The most recent insider transaction that took place on Jan 19, was worth 35,506. In this transaction Chief Medical Officer of this company sold 5,627 shares at a rate of $6.31, taking the stock ownership to the 59,373 shares. Before that another transaction happened on Oct 06, when Company’s VP of Finance and Controller sold 10,000 for $10.80, making the entire transaction worth $107,958. This insider now owns 110,366 shares in total.
Caribou Biosciences Inc. (CRBU) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 3/30/2023, it has been observed that the corporation posted -$0.46 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.49) by $0.03. This company achieved a net margin of -717.79 while generating a return on equity of -28.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -47.20% per share during the next fiscal year.
Caribou Biosciences Inc. (NASDAQ: CRBU) Trading Performance Indicators
You can see what Caribou Biosciences Inc. (CRBU) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.39 in one year’s time.
Technical Analysis of Caribou Biosciences Inc. (CRBU)
Caribou Biosciences Inc. (NASDAQ: CRBU) saw its 5-day average volume 0.55 million, a positive change from its year-to-date volume of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 49.86%. Additionally, its Average True Range was 0.31.
During the past 100 days, Caribou Biosciences Inc.’s (CRBU) raw stochastic average was set at 18.77%, which indicates a significant decrease from 93.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.88% in the past 14 days, which was higher than the 69.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.64, while its 200-day Moving Average is $7.63. Nevertheless, the first resistance level for the watch stands at $4.97 in the near term. At $5.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.48. If the price goes on to break the first support level at $4.45, it is likely to go to the next support level at $4.12. The third support level lies at $3.94 if the price breaches the second support level.
Caribou Biosciences Inc. (NASDAQ: CRBU) Key Stats
There are 61,364K outstanding shares of the company, which has a market capitalization of 287.90 million. As of now, sales total 13,850 K while income totals -99,420 K. Its latest quarter income was 3,500 K while its last quarter net income were -28,040 K.
